In the present study, activation of Chk1 is followed by inhibitory phosphorylation of CDK1 and it has been reported that pharmacologic and genetic inhibition of CDK137 or knock-down of upstream CDC25A38 induces differentiation through C/EBPα in AML cells with activated FLT3. The gene discussed is CEBPA; the disease is acute myeloid leukemia.